Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
163 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Británico de Buenos Aires
CABA, Buenos Aires, Argentina
Recruiting - Instituto Alexander Fleming
Caba, Buenos Aires, Argentina
Recruiting - Asociación de Beneficencia Hospital Sirio Libanés
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Recruiting - Hospital Italiano de Buenos Aires
ABB, Buenos Aires F.D., Argentina
Recruiting - Ionc Instituto Oncologico de Cordoba - Fundacion Richardet Longo
Córdoba, Argentina
Recruiting - Fundacion Centro Oncologico de Integración Regional
Mendoza, Argentina
Recruiting
- Macquarie University
Macquarie University, New South Wales, Australia
Recruiting - Genesiscare North Shore
St Leonards, New South Wales, Australia
Recruiting - Austin Health
Heidelberg, Victoria, Australia
Recruiting
- Klinik Ottakring
Vienna, State of Vienna, Austria
Recruiting - Medizinische Universität Wien
Vienna, State of Vienna, Austria
Recruiting - Medizinische Universitaet Innsbruck
Innsbruck, Tyrol, Austria
Recruiting
- Zas Augustinus
Wilrijk, Antwerpen, Belgium
Recruiting - Az Maria Middelares
Ghent, Oost-Vlaanderen, Belgium
Recruiting - Uz Gent
Ghent, Oost-Vlaanderen, Belgium
Recruiting - Centre Hospitalier Universitaire de Liège - Domaine Universitaire Du Sart Tilman
Liège, Belgium
Recruiting
- Local Institution - 0129
Salvador, Estado de Bahia, Brazil
Not, yet, recruiting - Local Institution - 0121
Porto Alegre, Rio Grande do Sul, Brazil
Not, yet, recruiting - Local Institution - 0130
Rio de Janeiro, Brazil
Not, yet, recruiting - Local Institution - 0124
São Paulo, Brazil
Not, yet, recruiting
- Local Institution - 0020
Edmonton, Alberta, Canada
Not, yet, recruiting - the Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
Recruiting - Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Recruiting - Mcgill University Health Centre
Montreal, Quebec, Canada
Recruiting
- Local Institution - 0050
Beijing, Beijing Municipality, China
Not, yet, recruiting - Local Institution - 0224
Beijing, Beijing Municipality, China
Not, yet, recruiting - Local Institution - 0048
Fuzhou, Fujian, China
Not, yet, recruiting - the First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Recruiting - Local Institution - 0056
Xiamen, Fujian, China
Not, yet, recruiting - Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Recruiting - the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Recruiting - Zhujiang Hospital
Guangzhou, Guangdong, China
Recruiting - Local Institution - 0064
Zhengzhou, Henan, China
Not, yet, recruiting - Local Institution - 0059
Changsha, Hunan, China
Not, yet, recruiting - Local Institution - 0046
Nanjing, Jiangsu, China
Not, yet, recruiting - Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
Recruiting - Local Institution - 0114
Nantong, Jiangsu, China
Not, yet, recruiting - the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Recruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Recruiting - the Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2025
- Primary completion
- 26 Jan 2029
- Completion
- 18 Nov 2033
- Last update posted
- 7 Jul 2026
- Registered enrollment
- 470
- Registry id
- NCT07106762
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.